TSX open
Loading markets…

Advertisement

Stocks/TSX/RVX

Resverlogix Corp. (RVX : TSX)

Common Stock

$0.10

CAD

+0.00 (%)

Last updated: 2026-07-31

Get RVX alerts:

RVX

Resverlogix Corp.

Source:WealthAwesomeWealthAwesome
$0.01 (11.11%)
30 day period
$0.09$0.10$0.11Jun 19Jul 13Jul 31

Performance

1 Day

+0.00%

1 Week

-9.09%

1 Month

+11.11%

YTD

+0.00%

Key Statistics

Market Cap

$30.11M

52W High

$0.15

52W Low

$0.09

P/E Ratio

-

50 Day MA

$0.10

200 Day MA

$0.11

Beta

1.05

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
7/31/2026$0.10$0.10$0.10$0.10$0.1014,900
7/30/2026$0.10$0.10$0.10$0.10$0.10117,000
7/29/2026$0.10$0.10$0.10$0.10$0.100
7/28/2026$0.10$0.10$0.10$0.10$0.10520
7/27/2026$0.11$0.11$0.11$0.11$0.110
7/24/2026$0.10$0.10$0.10$0.10$0.1037,116
7/23/2026$0.10$0.10$0.10$0.10$0.1043,914
7/22/2026$0.10$0.10$0.10$0.10$0.1056,400
7/21/2026$0.10$0.10$0.10$0.10$0.10500
7/20/2026$0.10$0.10$0.10$0.10$0.102,000

Analyst Price Targets

Based on analyst covering RVX

📈

Wall Street analysts forecast RVX stock price to rise 7600.0% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$7.70

+7600.0% Upside

Current Price

C$0.10

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on RVX's historical volatility

HistoricalForecast68%95%
C$0.03C$0.09C$0.14C$0.19C$0.24C$0.30TodayMar 23May 27Jul 31Sep 12Oct 26Dec 8

30-Day Vol

88.2%

Annualized

90-Day Vol

78.8%

Annualized

Trend (90d)

-0.0%

Annualized drift

90d Mean

C$0.10

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.10C$0.07C$0.14
60 trading daysC$0.10C$0.07C$0.15
90 trading daysC$0.10C$0.06C$0.17

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Resverlogix Corp.

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein, recent acute coronary syndrome, and post COVID-19 conditions. The company has a partnership with Eversana Life Science Services, LLC to support the commercialization of apabetalone for COVID-19 in the United States and Canada; developing cardiovascular and pulmonary arterial hypertension indications; and Medison Pharma Ltd. The company is headquartered in Calgary, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-4.55M
Profit Margin
0.00%
ROE (TTM)
0.00%
EPS (Diluted)
-0.03
Book Value
-0.40

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About RVX

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
ADCOAdcore Inc$0.14+0.00%
APLIAppili Therapeutics Inc$0.01+0.00%
ASCUArizona Sonoran Copper Company Inc$8.06+0.00%
ATCUAlta Copper Corp.$1.39+0.00%
AX-UNArtis Real Estate Investment Trust$25.61+0.00%
BBU-UNBrookfield Business Partners L.P.$45.79+0.00%
BITFBitfarms Ltd$8.24+0.00%
BNGBengal Energy Ltd$0.02+0.00%

RVX.TO news timeline

15 articles covering RVX.TO, most recent first

Latest

Why Resverlogix Corp. stock is skyrocketing today

Stocks

Advertisement